tiprankstipranks
Trending News
More News >
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN

Supernus Pharmaceuticals (SUPN) Revenue

Compare
502 Followers

Supernus Pharmaceuticals Revenue

Supernus Pharmaceuticals had a revenue of 174.16M in the quarter ending Dec 31, 2024, with -0.87%. This bring the company's revenue in the last twelve months to 661.82M, Decreased 1.51%. In the fiscal year ending Dec 31, 2024, Supernus Pharmaceuticals had annual revenue of 661.82M with 8.94% growth.
Revenue (ttm)
661.82M
Revenue Growth
11.82%
P/S Ratio
2.80
Revenue/Employee
$981,924
Employees
674
Market Cap
$1.86B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
661.82M54.30M+8.94%
Dec 31, 2023
607.52M-59.72M-8.95%
Dec 31, 2022
667.24M87.46M+15.09%
Dec 31, 2021
579.77M59.38M+11.41%
Dec 31, 2020
520.40M127.64M+32.50%
Dec 31, 2019
392.75M-16.14M-3.95%
Dec 31, 2018
408.90M106.66M+35.29%
Dec 31, 2017
302.24M87.23M+40.57%
Dec 31, 2016
215.00M70.58M+48.87%
Dec 31, 2015
144.43M22.38M+18.34%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis